top of page

We are here to modernize
reproductive care

 Gynecologic health made easy 

BUT_Sketch Renderlings-13.png

Non-surgical diagnostics and treatment

Delivers the world’s first

non-surgical fertility/infertility diagnostics and treatment that can be done by any Ob/Gyn physician.

BUT_Sketch Renderlings-14.png

In-office process

Champions the move to local doctor’s offices without the need or expense of a specialized clinic.

BUT_Sketch Renderlings-15.png

More efficient

Eliminates the need for surgery and associated specialists/costs: surgical theater, anesthesia, etc.

BUT_Sketch Renderlings-16.png

Safe experience

Provides women with safe, easy, and effective uterine care and a much-enhanced treatment experience.

BUT_Sketch Renderlings-10.png


Creates a game-changing

low-cost alternative to

traditional IVF.

BUT_Sketch Renderlings-17.png


Opens and expands multiple, global universally-unserved fertility and infertility markets.

Our mission

Deliver the world’s first non-surgical platform for fertility (egg/embryo retrieval) and uterine diagnostics and treatment.


We see a world where everyone can access safe, effective, and affordable fertility and gynecologic care.

Científico con microscopio

Our technology 

Our unique technology is IP-protected with 11 US patents, 1 foreign–issued patent, and 12 patents pending, providing a comprehensive, easy-to-use in-office solution for the majority of intrauterine procedures.

We have created the world’s first non-surgical fertility Platform and treatments that will transform and expand fertility care by making treatments available through the network of tens of thousands of Ob/Gyn physicians in the US and around the world.

Una mujer sonriendo mientras trabaja

Our trajectory

We are currently pre-market and post-pivotal study. Our Platform is fully validated for its intended uses, and we are currently undergoing regulatory approval and development of our manufacturing capability.

We anticipate FDA regulatory for gynecologic care in 2023, approval for gynecologic and fertility care in Europe in early 2024, and full approval in the USA for fertility care in late 2024. 

Tableta médica

Be part of the transformation

If you’re interested in joining our mission and starting transforming women's health.

We'd love to hear from you.

bottom of page